Article Versions Notes

Dri DA, Gaucci E, Torrieri I, Carafa M, Marianecci C, Gramaglia D. Critical Analysis and Quality Assessment of Nanomedicines and Nanocarriers in Clinical Trials: Three Years of Activity at the Clinical Trials Office. Pharmaceutics. 2022; 14(7):1438. https://doi.org/10.3390/pharmaceutics14071438

Dri, Diego Alejandro, Elisa Gaucci, Ilaria Torrieri, Maria Carafa, Carlotta Marianecci, and Donatella Gramaglia. 2022. "Critical Analysis and Quality Assessment of Nanomedicines and Nanocarriers in Clinical Trials: Three Years of Activity at the Clinical Trials Office" Pharmaceutics 14, no. 7: 1438. https://doi.org/10.3390/pharmaceutics14071438

Dri, D. A., Gaucci, E., Torrieri, I., Carafa, M., Marianecci, C., & Gramaglia, D. (2022). Critical Analysis and Quality Assessment of Nanomedicines and Nanocarriers in Clinical Trials: Three Years of Activity at the Clinical Trials Office. Pharmaceutics, 14(7), 1438. https://doi.org/10.3390/pharmaceutics14071438